Cargando…
The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis
BACKGROUND: Patients with ER-negative breast tumors are among the most difficult to treat and exhibit low survival rates due, in part, to metastasis from the breast to various distal sites. Aryl hydrocarbon receptor (AHR) ligands show promise as antimetastatic drugs for estrogen receptor (ER)-negati...
Autores principales: | Jin, Un-Ho, Lee, Syng-Ook, Pfent, Catherine, Safe, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226953/ https://www.ncbi.nlm.nih.gov/pubmed/25011475 http://dx.doi.org/10.1186/1471-2407-14-498 |
Ejemplares similares
-
Aryl Hydrocarbon Receptor (AHR) Ligands as Selective AHR Modulators (SAhRMs)
por: Safe, Stephen, et al.
Publicado: (2020) -
The Role of the Aryl Hydrocarbon Receptor (AhR) and Its Ligands in Breast Cancer
por: Safe, Stephen, et al.
Publicado: (2022) -
Omeprazole Inhibits Glioblastoma Cell Invasion and Tumor Growth
por: Jin, Un-Ho, et al.
Publicado: (2020) -
Flavonoids kaempferol and quercetin are nuclear receptor 4A1 (NR4A1, Nur77) ligands and inhibit rhabdomyosarcoma cell and tumor growth
por: Shrestha, Rupesh, et al.
Publicado: (2021) -
Differential Effects of Omeprazole and Lansoprazole Enantiomers on Aryl Hydrocarbon Receptor in Human Hepatocytes and Cell Lines
por: Novotna, Aneta, et al.
Publicado: (2014)